OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer
Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Kehinde Ross, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Various Approaches for the Detoxification of Toxic Dyes in Wastewater
Abdulmohsen Khalaf Dhahi Alsukaibi
Processes (2022) Vol. 10, Iss. 10, pp. 1968-1968
Open Access | Times Cited: 190

Electrochemiluminescence biosensors for detection of cancer biomarkers in biofluids: Principles, opportunities, and challenges
Ahmed Barhoum, Zeynep Altıntaş, K. S. Shalini Devi, et al.
Nano Today (2023) Vol. 50, pp. 101874-101874
Closed Access | Times Cited: 66

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 50

Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 27

Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24

Extrachromosomal circular DNA: biogenesis, structure, functions and diseases
Ludi Yang, Ruobing Jia, Tongxin Ge, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 48

Mitochondrial Metabolism: A New Dimension of Personalized Oncology
Babak Behnam, Farzad Taghizadeh‐Hesary
Cancers (2023) Vol. 15, Iss. 16, pp. 4058-4058
Open Access | Times Cited: 25

CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening
Guangshun Sun, Siqi Zhao, Zhongguo Fan, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 22

CRISPR/Cas detection with nanodevices: moving deeper into liquid biopsy
Huimin Kong, Ke Yi, Rachel L. Mintz, et al.
Chemical Communications (2024) Vol. 60, Iss. 17, pp. 2301-2319
Closed Access | Times Cited: 9

Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments
Shalindu Malshan Jayawickrama, Piyumi Madhushani Ranaweera, Roshan Pradeep, et al.
Cancer Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 8

Exploring the Cytotoxic and Anticancer Potential of Naringin on Oral Cancer Cell Line
Beniel Vincer, Jospin Sindya, Jeevitha Rajanathadurai, et al.
Cureus (2024)
Open Access | Times Cited: 5

Advances in Molecular Mechanisms and Therapeutic Strategies in Colorectal Cancer: A New Era of Precision Medicine
Donatella Delle Cave
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 346-346
Open Access

Piwi-interacting RNA biomarkers in gastrointestinal disease
Xin-Yi Huang, Shuxian Chen, Zhenyu Wang, et al.
Clinica Chimica Acta (2025) Vol. 569, pp. 120182-120182
Closed Access

Cell cycle‐based antibody selection for suppressing cancer cell growth
Chi Hun Song, Chih‐Wei Lin, Kyung Ho Han
The FASEB Journal (2025) Vol. 39, Iss. 4
Open Access

PERSONALIZED MEDICINE IN ORAL CANCER
Shalini Gupta, Arushi Tomar, Riya Singh
Critical Reviews in Oncology/Hematology (2025), pp. 104670-104670
Closed Access

Investigating Neurodegenerative Diseases From Alzheimer's to Parkinson's
Noopur Khare, Pragati Khare, Swati Priyadarshi
Advances in medical education, research, and ethics (AMERE) book series (2025), pp. 399-436
Closed Access

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
Domenico Tierno, Gabriele Grassi, Serena Scomersi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9688-9688
Open Access | Times Cited: 13

The epigenetic modification of DNA methylation in neurological diseases
Linke Li, R Chen, Hui Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

CRISPR genome editing using computational approaches: A survey
Roghayyeh Alipanahi, Leila Safari, Alireza Khanteymoori
Frontiers in Bioinformatics (2023) Vol. 2
Open Access | Times Cited: 11

CRISPR applications in cancer diagnosis and treatment
Mingxia Wang, Menghui Chen, Xia Wu, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 11

Pan-cancer single-cell landscape of drug-metabolizing enzyme genes
Wei Mao, Tao Zhou, Feng Zhang, et al.
Pharmacogenetics and Genomics (2024)
Closed Access | Times Cited: 3

Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing
S. Sowmya, Dominic Augustine, Shazia Mushtaq, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3

Advances and Prospects in Liquid Biopsy Techniques for Malignant Tumor Diagnosis and Surveillance
C. Zhang, Tenghui Li, Qian Zhao, et al.
Small (2024) Vol. 20, Iss. 44
Open Access | Times Cited: 3

Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star
Qun Chen, Jiajia Li, Peng Shen, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16

Page 1 - Next Page

Scroll to top